PFS | OS | ||||||
---|---|---|---|---|---|---|---|
HR* | 95% CI | P value | HR | 95% CI | P value | ||
Sex | 0.676 | 0.236–1.932 | 0.465 | 1.572 | 0.447–5.520 | 0.481 | |
Age | 0.943 | 0.360–2.469 | 0.904 | 0.699 | 0.265–1.842 | 0.469 | |
Primary tumor sites | 1.163 | 0.401–3.373 | 0.782 | 0.874 | 0.281–2.716 | 0.816 | |
ECOG PS | 0.885 | 0.285–2.752 | 0.833 | 1.080 | 0.306–3.816 | 0.905 | |
Cancer grading | 0.396 | 0.090–1.739 | 0.220 | 1.090 | 0.349–3.403 | 0.882 | |
Lauren typing | 0.297 | 0.095–0.926 | 0.036 | 0.529 | 0.169–1.656 | 0.274 | |
Liver Metastasis | 0.187 | 0.042–0.840 | 0.029 | 0.214 | 0.049–0.947 | 0.042 | |
Metastasis site | 0.430 | 0.161–1.151 | 0.093 | 0.595 | 0.220–1.606 | 0.306 | |
Previous regimen | 0.046 | 0-15955.418 | 0.636 | 2.688 | 0.340-21.246 | 0.348 | |
Chemotherapy lines | 1.123 | 0.318–3.968 | 0.858 | 1.213 | 0.345–4.268 | 0.764 |